Pharmaceutical expenditure in Sweden

Health Policy

Volumn 47, Issue 2, 1999, Pages 125-144

  Henriksson, Freddie ^a   Hjortsberg, Catharina ^b   Rehnberg, Clas ^a  

^a STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

^b SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

Author keywords

Age; Disease categories; Market segments; Pharmaceutical expenditures; Policy implications; Reform

Indexed keywords

AGING; ARTICLE; CONSUMER; DRUG COST; DRUG INDUSTRY; FINANCE; FINANCIAL MANAGEMENT; HEALTH CARE COST; PRESCRIPTION; SWEDEN;

AGE DISTRIBUTION; DISEASE; DRUG COSTS; DRUG THERAPY; ECONOMICS, PHARMACEUTICAL; FEMALE; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; MALE; STATE MEDICINE; SWEDEN;

EID: 0033049098     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(99)00016-0     Document Type: Article

References (22)

1. Gerdtham U.-G., Johannesson M., Gunnarsson B., Marcusson M., Henriksson F. The effect of changes in treatment patterns on drug expenditure. Pharmacoeconomics. 13:1998;127-134.
2. Klassifikation av Sjukdomar 1987. Systematisk Förteckning. 1986;Liber Förlag, Stockholm. (in Swedish).
3. OECD. Health Data Base. Organisation for Economic Cooperation and Development, Paris, 1996 and 1998 (electronic publication).
4. Ward M. Purchasing Power Parities and Real Expenditures in the OECD. 1985;Organisation for Economic Cooperation and Development, Paris.
5. Arvidsson G., Jönsson B. Politik och Marknad i Framtidens Sjukvård (Red.). 1997;SNS, Stockholm. (in Swedish).
6. National Corporation of Swedish Pharmacies. Stockholm: Swedish Pharmaceutical Statistics, various years.
7. Reform på Recept. Delbetänkande av Kommittén om Hälso- och Sjukvårdens Finansiering och Organisation (HSU 2000). SOU. 122:1995.
8. Henriksson F, Hjortsberg C, Rehnberg C, Ödegaard K. Läkemedlen och sjukvårdskostnaderna. Några utvecklingslinjer. IHE Working Paper 1997:6 (in Swedish).
9. Hodgson T.A., Meiners M.R. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q. 60:1982;429-491.
10. Lindgren B. Costs of illness in Sweden 1964-1975. Doctoral Thesis. Lund Economic Studies 24. University of Lund, Department of Economics, 1981.
11. Rice D.P. Estimating the cost of illness. Health Economics Series. 6:1966;US Government Printing Office, Public Health Service, Washington, DC.
12. Kostnad per Intagen Patient. Vårddag, Läkarbesök mm 1993. 1994;Enskede Offset, Enskede.
13. National Corporation of Swedish Pharmacies. Medical Index Sweden. Stockholm: different years.
14. National Board of Health and Welfare. Data from The In-patient Register. L. Forsberg, Epidemiologial Centre, personal communication, 1996.
15. Nybeviljade förtidspensioner 1971-1994. Stat. Inform. Is-I. 2:1995;. (in Swedish).
16. Sjukdomar som orsakat pensionering bland förtidspensionärerna i December 1991. Stat. Rep. Is-R. 2:1995;. (in Swedish).
17. Sjukfrånvarons Diagnoser och Avslutningsanledningar 1990. 1995;National Social Insurance Board, Stockholm. (in Swedish).
18. Causes of Death in 1993 (in Hälsa och sjukdomar). SOU. 16:1996.
19. Jacobson L., Lindgren B. Vad Kostar Sjukdomarna? Sjukvårdskostnader och Produktionsbortfall Fördelat på Sjukdomsgrupper 1980 och 1991. 1996;National Board of Health and Welfare, Stockholm. (in Swedish).
20. Gerdtham U.-G. The impact of ageing on health care expenditure in Sweden. Health Policy. 24:1993;1-8.
21. Population. 1994;Sveriges Framtida Befolkning, Örebro. (in Swedish).
22. Henriksson F, Jönsson B. Diabetes - The Cost of Illness in Sweden. Journal of Internal Medicine 1998;244:461-468.